Alyeska Investment Group’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.96M | Buy |
244,775
+80,135
| +49% | +$2.61M | 0.03% | 376 |
|
|
2025
Q1 | $6.22M | Sell |
164,640
-32,945
| -17% | -$1.24M | 0.02% | 345 |
|
|
2024
Q4 | $16.2M | Sell |
197,585
-21,246
| -10% | -$1.74M | 0.06% | 281 |
|
|
2024
Q3 | $25M | Buy |
+218,831
| New | +$25M | 0.13% | 215 |
|
|
2024
Q1 | – | Sell |
-25,000
| Closed | -$1.57M | – | 556 |
|
|
2023
Q4 | $1.57M | Hold |
25,000
| – | – | 0.01% | 362 |
|
|
2023
Q3 | $1.27M | Hold |
25,000
| – | – | 0.01% | 396 |
|
|
2023
Q2 | $1.25M | Sell |
25,000
-20,000
| -44% | -$999K | 0.01% | 410 |
|
|
2023
Q1 | $1.69M | Hold |
45,000
| – | – | 0.01% | 350 |
|
|
2022
Q4 | $2.16M | Sell |
45,000
-7,100
| -14% | -$340K | 0.02% | 310 |
|
|
2022
Q3 | $1.25M | Hold |
52,100
| – | – | 0.01% | 334 |
|
|
2022
Q2 | $1.13M | Hold |
52,100
| – | – | 0.01% | 454 |
|
|
2022
Q1 | $1.26M | Buy |
+52,100
| New | +$1.26M | 0.01% | 479 |
|